Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–1 of 1 stories
The article discusses the potential of lentiviral-based gene therapy for treating rare genetic diseases affecting the brain and spinal cord, including X-linked adrenoleukodystrophy, metachromatic leukodystrophy, and mucopolysaccharidoses. It highlights the aim of improving enzyme bioavailability and correcting neuropathological phenotypes.
Read full storyGet the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.